What is EKF Diagnostics Holdings Enterprise Value?
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, EKF Diagnostics Holdings's Enterprise Value is €172.24 Mil.
EKF Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €2.56 Mil. Therefore, EKF Diagnostics Holdings's EV-to-EBIT ratio for today is 67.25.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of EKF Diagnostics Holdings's Enterprise Value
For the Medical Devices subindustry, EKF Diagnostics Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EKF Diagnostics Holdings's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's Enterprise Value distribution charts can be found below:
* The bar in red indicates where EKF Diagnostics Holdings's Enterprise Value falls into.
EKF Diagnostics Holdings Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EKF Diagnostics Holdings's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EKF Diagnostics Holdings (FRA:LYF) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
EKF Diagnostics Holdings's EV-to-EBIT for today is
EKF Diagnostics Holdings's current Enterprise Value is €172.24 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. EKF Diagnostics Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €2.56 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
EKF Diagnostics Holdings's EV-to-EBITDA for today is:
EKF Diagnostics Holdings's current Enterprise Value is €172.24 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. EKF Diagnostics Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €8.93 Mil.
EKF Diagnostics Holdings's current Enterprise Value is €172.24 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. EKF Diagnostics Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €61.19 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EKF Diagnostics Holdings Enterprise Value Related Terms
Thank you for viewing the detailed overview of EKF Diagnostics Holdings's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
EKF Diagnostics Holdings (FRA:LYF) Business Description
EKF Diagnostics Holdings PLC is engaged in the field of medical diagnostics. The company's core business is point-of-care testing and manufacturing reagents for use in central laboratories. It caters to companies focused on areas such as diabetes, blood banking, and sports medicine. The company derives its income from its sales in the United States. Its other markets include Germany, Poland, and Russia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:LYF has been successfully added to your 